Elevance Health (ELV) — insider trading
Health Care
Elevance Health (ELV) has 17 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases and 3 open-market sales among the most recent 17 (latest 2026-07-17).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | BOUDREAUX GAIL | Director, Officer (President and CEO) | Open-market purchase | 2,045 | $368.25 | $753.1K | Form 4 |
| 2026-07-17 | BOUDREAUX GAIL | Director, Officer (President and CEO) | Open-market purchase | 680 | $366.41 | $249.2K | Form 4 |
| 2026-07-17 | PERU RAMIRO G | Director | Open-market purchase | 1,000 | $366.05 | $366.1K | Form 4 |
| 2026-06-12 | Penczek Ronald W | Officer (CAO & Controller) | Open-market sale | 369 | $403.16 | $148.8K | Form 4 |
| 2026-06-11 | Dixon Robert L JR | Director | Open-market sale | 151 | $401.77 | $60.7K | Form 4 |
| 2026-05-19 | Penczek Ronald W | Officer (CAO & Controller) | Option exercise / conversion (derivative) | 877 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Penczek Ronald W | Officer (CAO & Controller) | Option exercise / conversion (derivative) | 654 | $0.00 | $0 | Form 4 |
| 2026-05-19 | Penczek Ronald W | Officer (CAO & Controller) | Open-market sale | 1,531 | $403.13 | $617.2K | Form 4 |
| 2026-05-19 | Penczek Ronald W | Officer (CAO & Controller) | Option exercise / conversion | 877 | $311.48 | $273.2K | Form 4 |
| 2026-05-19 | Penczek Ronald W | Officer (CAO & Controller) | Option exercise / conversion | 654 | $271.27 | $177.4K | Form 4 |
| 2026-05-13 | HAY LEWIS III | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Jallal Bahija | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Neri Antonio F | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | PERU RAMIRO G | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Schneider Ryan M. | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | SCHULMAN AMY W | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | Director | Grant / award / vesting | 563 | $0.00 | $0 | Form 4 |
Ask the chat about ELV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Elevance Health (ELV).
Last updated 2026-07-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.